Component

Rat carnitine-acylcarnitine translocase / Slc25a20

Context-specific entity; species, compartment and exposure are stated on each claim.

3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Purified rat mitochondrial CACT reconstituted into liposomes exchanged carnitine and transported acylcarnitines of several chain lengths.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Recombinant rat carrier and proteoliposomes.
    limitations
    Transport reconstitution is not a human flux measurement.
    nutrient_topic
    L-Carnitine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnitine
    plain_language
    A separate carrier moves the loaded molecule across the inner membrane.
    primary_references
    Bacterial overexpression, purification, and reconstitution of the carnitine/acylcarnitine carrier from rat liver mitochondria. · 1998 · https://pubmed.ncbi.nlm.nih.gov/9731180/ · DOI 10.1006/bbrc.1998.9197

    L-Carnitine: synthesis, acyl-group transport, fuel selection and nutrient interactions (2026-09-19) · lines 98–104

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Recombinant rat carrier and proteoliposomes. · source_derived_draft · unverified_draft

    ## l-carnitine-cact-exchange A separate carrier moves the loaded molecule across the inner membrane. Purified rat mitochondrial CACT reconstituted into liposomes exchanged carnitine and transported acylcarnitines of several chain lengths. Model: Recombinant rat carrier and proteoliposomes. Limitations: Transport reconstitution is not a human flux measurement. Evidence access: Primary abstract Bacterial overexpression, purification, and reconstitution of the carnitine/acylcarnitine carrier from rat liver mitochondria. · 1998 · https://pubmed.ncbi.nlm.nih.gov/9731180/ · DOI 10.1006/bbrc.1998.9197
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. Copper inhibited rat-liver CACT carnitine exchange in proteoliposomes, with a native-protein IC50 of 1.6 micromolar.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Native rat-liver carrier; recombinant cysteine mutants supported involvement of C136 and C155.
    limitations
    Free copper in an assay is not dietary copper exposure; no clinical deficiency or toxicity threshold follows.
    nutrient_topic
    L-Carnitine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnitine
    plain_language
    Metal exposure can interfere with the carrier in a controlled assay.
    primary_references
    Effect of Copper on the Mitochondrial Carnitine/Acylcarnitine Carrier Via Interaction with Cys136 and Cys155. Possible Implications in Pathophysiology. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32070004/ · DOI 10.3390/molecules25040820

    L-Carnitine: synthesis, acyl-group transport, fuel selection and nutrient interactions (2026-09-19) · lines 138–144

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Native rat-liver carrier; recombinant cysteine mutants supported involvement of C136 and C155. · source_derived_draft · unverified_draft

    ## l-carnitine-copper-carrier Metal exposure can interfere with the carrier in a controlled assay. Copper inhibited rat-liver CACT carnitine exchange in proteoliposomes, with a native-protein IC50 of 1.6 micromolar. Model: Native rat-liver carrier; recombinant cysteine mutants supported involvement of C136 and C155. Limitations: Free copper in an assay is not dietary copper exposure; no clinical deficiency or toxicity threshold follows. Evidence access: Primary abstract Effect of Copper on the Mitochondrial Carnitine/Acylcarnitine Carrier Via Interaction with Cys136 and Cys155. Possible Implications in Pathophysiology. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32070004/ · DOI 10.3390/molecules25040820
    Complete structured claim and evidence
  2. Adding reduced glutathione reversed copper inhibition of the reconstituted native rat carnitine-acylcarnitine carrier.

    GSH → Rat mitochondrial CACT transport activity source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Rat-liver CACT proteoliposome assay.
    limitations
    Does not demonstrate oral glutathione-carnitine synergy.
    nutrient_topic
    L-Carnitine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnitine
    plain_language
    The redox environment can change whether the carrier works.
    primary_references
    Effect of Copper on the Mitochondrial Carnitine/Acylcarnitine Carrier Via Interaction with Cys136 and Cys155. Possible Implications in Pathophysiology. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32070004/ · DOI 10.3390/molecules25040820

    L-Carnitine: synthesis, acyl-group transport, fuel selection and nutrient interactions (2026-09-19) · lines 146–152

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Rat-liver CACT proteoliposome assay. · source_derived_draft · unverified_draft

    ## l-carnitine-gsh-carrier The redox environment can change whether the carrier works. Adding reduced glutathione reversed copper inhibition of the reconstituted native rat carnitine-acylcarnitine carrier. Model: Rat-liver CACT proteoliposome assay. Limitations: Does not demonstrate oral glutathione-carnitine synergy. Evidence access: Primary abstract Effect of Copper on the Mitochondrial Carnitine/Acylcarnitine Carrier Via Interaction with Cys136 and Cys155. Possible Implications in Pathophysiology. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32070004/ · DOI 10.3390/molecules25040820
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards